Clinical Trial Update: Safety and Efficacy of T89 in the Prevention and Treatment of Adults With Acute Mountain Sickness (AMS) [Phase 3]

View source ↗

Summary

Phase 3 clinical trial assessing the safety and efficacy of T89 for prevention and treatment of Acute Mountain Sickness in adults; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mountain Sickness

Drugs mentioned

• T89

Snippet

Sponsor: Tasly Pharmaceuticals, Inc. | Conditions: Acute Mountain Sickness (AMS) | Phase 3 | Status: COMPLETED